16.26
前日終値:
$15.85
開ける:
$15.85
24時間の取引高:
4.02M
Relative Volume:
1.83
時価総額:
$1.40B
収益:
$139.71M
当期純損益:
$-209.36M
株価収益率:
-5.4932
EPS:
-2.96
ネットキャッシュフロー:
$-160.60M
1週間 パフォーマンス:
+3.30%
1か月 パフォーマンス:
+68.85%
6か月 パフォーマンス:
+6.41%
1年 パフォーマンス:
-21.86%
Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile
名前
Syndax Pharmaceuticals Inc
セクター
電話
781-419-1400
住所
730 THIRD AVENUE, NEW YORK, MA
SNDX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
SNDX
Syndax Pharmaceuticals Inc
|
16.26 | 1.37B | 139.71M | -209.36M | -160.60M | -2.96 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-05 | 繰り返されました | BTIG Research | Buy |
2025-07-10 | 開始されました | Goldman | Buy |
2024-10-24 | 開始されました | UBS | Buy |
2024-06-28 | 開始されました | Jefferies | Buy |
2024-01-31 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
2023-12-22 | 開始されました | Mizuho | Buy |
2023-10-25 | 開始されました | BofA Securities | Buy |
2023-10-11 | 開始されました | Goldman | Buy |
2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
2023-07-11 | 開始されました | Guggenheim | Buy |
2023-04-17 | 再開されました | BTIG Research | Buy |
2023-01-31 | 開始されました | Stifel | Buy |
2023-01-03 | 開始されました | JP Morgan | Overweight |
2022-07-28 | 再開されました | B. Riley Securities | Buy |
2022-04-11 | 開始されました | H.C. Wainwright | Buy |
2022-02-15 | 開始されました | Goldman | Buy |
2021-06-04 | 再開されました | Robert W. Baird | Outperform |
2021-05-25 | 開始されました | Citigroup | Buy |
2021-02-18 | 開始されました | B. Riley Securities | Buy |
2020-12-03 | 開始されました | Stifel | Buy |
2020-05-22 | アップグレード | Citigroup | Neutral → Buy |
2020-05-22 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-05-18 | ダウングレード | Citigroup | Buy → Neutral |
2020-05-11 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-04 | 開始されました | Barclays | Overweight |
2020-01-13 | 繰り返されました | H.C. Wainwright | Buy |
2019-03-08 | 繰り返されました | H.C. Wainwright | Buy |
2019-01-04 | 開始されました | Robert W. Baird | Outperform |
2018-01-05 | 開始されました | B. Riley FBR, Inc. | Buy |
2017-03-16 | 開始されました | FBR & Co. | Outperform |
2017-03-02 | 開始されました | Instinet | Buy |
2016-10-07 | 開始されました | Guggenheim | Buy |
2016-03-28 | 開始されました | Citigroup | Buy |
2016-03-28 | 開始されました | JMP Securities | Mkt Outperform |
2016-03-28 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Syndax Pharmaceuticals Inc (SNDX) 最新ニュース
What the charts say about Syndax Pharmaceuticals Inc. todayOptions Play & Weekly Breakout Watchlists - Newser
Applying chart zones and confluence areas to Syndax Pharmaceuticals Inc.July 2025 Levels & Low Drawdown Momentum Ideas - Newser
Can machine learning forecast Syndax Pharmaceuticals Inc. recoveryJuly 2025 Technicals & Safe Capital Growth Plans - Newser
How to track smart money flows in Syndax Pharmaceuticals Inc.Weekly Market Summary & Real-Time Price Movement Reports - Newser
Can trapped investors hope for a rebound in Syndax Pharmaceuticals Inc.Weekly Gains Report & Community Consensus Trade Alerts - Newser
When is the best time to exit Syndax Pharmaceuticals Inc.Market Growth Summary & AI Optimized Trade Strategies - Newser
Detecting price anomalies in Syndax Pharmaceuticals Inc. with AIStop Loss & Expert Verified Movement Alerts - Newser
Candriam S.C.A. Has $5.53 Million Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Aberdeen Group plc Acquires 33,093 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Sentiment analysis tools applied to Syndax Pharmaceuticals Inc.July 2025 Breakouts & Precise Trade Entry Recommendations - Newser
Real time breakdown of Syndax Pharmaceuticals Inc. stock performanceEarnings Beat & Stock Portfolio Risk Control - Newser
Signal strength of Syndax Pharmaceuticals Inc. stock in tech scannersEarnings Recap Summary & Fast Entry High Yield Stock Tips - Newser
Custom strategy builders for tracking Syndax Pharmaceuticals Inc.July 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Will Syndax Pharmaceuticals Inc. continue its uptrendMarket Growth Review & Step-by-Step Trade Execution Guides - Newser
Syndax Announces Participation in September Investor Conferences | SNDX Stock News - GuruFocus
Syndax Pharmaceuticals to present at Citi BioPharma Back to School Conference. - AInvest
Syndax to Participate in September Investor Conferences - AInvest
Syndax Announces Participation in September Investor Conferences - Yahoo Finance
Deutsche Bank AG Buys 114,828 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
What’s the profit margin of Syndax Pharmaceuticals Inc.2025 Earnings Surprises & Weekly Market Pulse Updates - sundaytimes.kr
What Fibonacci levels say about Syndax Pharmaceuticals Inc. reboundQuarterly Profit Summary & High Win Rate Trade Tips - Newser
Will Syndax Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsGap Down & Weekly Return Optimization Plans - Newser
What MACD and RSI say about Syndax Pharmaceuticals Inc.Market Sentiment Report & Free Growth Oriented Trading Recommendations - Newser
Is Syndax Pharmaceuticals Inc. exposed to currency risksQuarterly Portfolio Report & Accurate Buy Signal Notifications - theviewers.co.kr
Syndax Pharmaceuticals (NASDAQ:SNDX) Director Sells $298,368.00 in Stock - MarketBeat
How high can Syndax Pharmaceuticals Inc. stock price go in 2025July 2025 Setups & Verified Swing Trading Watchlists - Newser
Analyzing net buyer seller activity in Syndax Pharmaceuticals Inc.Weekly Gains Report & Weekly Watchlist for Hot Stocks - Newser
Is Syndax Pharmaceuticals Inc. stock forming a triangle pattern2025 Geopolitical Influence & Short-Term High Return Ideas - theviewers.co.kr
Real time social sentiment graph for Syndax Pharmaceuticals Inc.July 2025 Big Picture & AI Enhanced Trading Alerts - Newser
Syndax Pharmaceuticals (NASDAQ:SNDX) Director Sells $304,128.00 in Stock - MarketBeat
Published on: 2025-08-23 04:15:34 - theviewers.co.kr
Syndax Pharmaceuticals’ Axatilimab Study: A Potential Breakthrough for IPF Treatment - TipRanks
Can Syndax Pharmaceuticals Inc. Rally Enough to Break EvenJuly 2025 Outlook & Daily Stock Momentum Reports - beatles.ru
Algert Global LLC Purchases 98,968 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals Inc. Stock Lags Behind Sector BenchmarksQuarterly Profit Summary & Weekly Chart Analysis and Trade Guides - beatles.ru
Syndax Pharmaceuticals (NASDAQ:SNDX) Trading 4.4% HigherHere's What Happened - MarketBeat
Predicting Syndax Pharmaceuticals Inc. trend using moving averagesWatch List & Fast Entry Momentum Alerts - Newser
Regulatory Milestone and Analyst Optimism Fuel Momentum for Syndax Pharmaceuticals - MSN
Aigen Investment Management LP Invests $297,000 in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals Director Podlesak Dennis Makes Large Trades in August 2025 - AInvest
Syndax signals $4B total market opportunity with Revuforj expansion into frontline settings - MSN
BTIG Raises Syndax Pharmaceuticals (SNDX) PT to $56 Following Strong Q2 Revenue from Revuforj, Niktimvo - Yahoo Finance
Syndax Pharmaceuticals Inc. stock daily chart insightsMarket Rally & Low Drawdown Investment Ideas - Newser
Syndax Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:SNDX) - MarketBeat
Published on: 2025-08-17 17:19:16 - theviewers.co.kr
Will breakout in Syndax Pharmaceuticals Inc. lead to full recoveryJuly 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - Newser
Syndax Pharmaceuticals Inc (SNDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):